Free Trial

D-Wave Quantum (QBTS) Competitors

D-Wave Quantum logo
$8.72 +0.36 (+4.25%)
Closing price 03:59 PM Eastern
Extended Trading
$8.65 -0.06 (-0.75%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

QBTS vs. RTO, ALLE, FTAI, CART, ULS, MEDP, STN, BILI, WPP, and HQY

Should you be buying D-Wave Quantum stock or one of its competitors? The main competitors of D-Wave Quantum include Rentokil Initial (RTO), Allegion (ALLE), FTAI Aviation (FTAI), Maplebear (CART), UL Solutions (ULS), Medpace (MEDP), Stantec (STN), Bilibili (BILI), WPP (WPP), and HealthEquity (HQY). These companies are all part of the "business services" industry.

D-Wave Quantum vs.

Rentokil Initial (NYSE:RTO) and D-Wave Quantum (NYSE:QBTS) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings.

Rentokil Initial has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, D-Wave Quantum has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.

Rentokil Initial has a net margin of 0.00% compared to D-Wave Quantum's net margin of -783.28%.

Company Net Margins Return on Equity Return on Assets
Rentokil InitialN/A N/A N/A
D-Wave Quantum -783.28%N/A -134.62%

9.9% of Rentokil Initial shares are owned by institutional investors. Comparatively, 42.5% of D-Wave Quantum shares are owned by institutional investors. 7.2% of D-Wave Quantum shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Rentokil Initial has higher revenue and earnings than D-Wave Quantum. D-Wave Quantum is trading at a lower price-to-earnings ratio than Rentokil Initial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rentokil Initial$5.44B2.10$473.93M$1.5114.95
D-Wave Quantum$8.83M264.46-$82.71M-$0.69-12.57

D-Wave Quantum received 26 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 88.57% of users gave D-Wave Quantum an outperform vote while only 35.71% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
Rentokil InitialOutperform Votes
5
35.71%
Underperform Votes
9
64.29%
D-Wave QuantumOutperform Votes
31
88.57%
Underperform Votes
4
11.43%

D-Wave Quantum has a consensus target price of $8.42, indicating a potential downside of 2.96%. Given D-Wave Quantum's stronger consensus rating and higher probable upside, analysts clearly believe D-Wave Quantum is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rentokil Initial
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71
D-Wave Quantum
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, D-Wave Quantum had 45 more articles in the media than Rentokil Initial. MarketBeat recorded 48 mentions for D-Wave Quantum and 3 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.72 beat D-Wave Quantum's score of 0.57 indicating that Rentokil Initial is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rentokil Initial
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
D-Wave Quantum
16 Very Positive mention(s)
14 Positive mention(s)
14 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Rentokil Initial and D-Wave Quantum tied by winning 9 of the 18 factors compared between the two stocks.

Remove Ads
Get D-Wave Quantum News Delivered to You Automatically

Sign up to receive the latest news and ratings for QBTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QBTS vs. The Competition

MetricD-Wave QuantumData processing & preparation IndustryComputer SectorNYSE Exchange
Market Cap$2.33B$3.99B$24.15B$19.74B
Dividend YieldN/A3.39%2.79%3.75%
P/E Ratio-20.6567.7543.2433.98
Price / Sales264.46657.162,340.1628.92
Price / CashN/A33.7434.6517.54
Price / Book-57.826.106.374.63
Net Income-$82.71M$43.33M$735.89M$1.02B
7 Day Performance-22.60%-0.03%1.03%0.68%
1 Month Performance35.30%-6.27%49,591.93%-1.47%
1 Year Performance347.06%13.89%52,706.38%7.05%

D-Wave Quantum Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QBTS
D-Wave Quantum
0.9027 of 5 stars
$8.72
+4.2%
$8.42
-3.4%
+331.6%$2.35B$8.83M-20.753Gap Up
High Trading Volume
RTO
Rentokil Initial
2.5212 of 5 stars
$22.25
+1.8%
N/A-25.4%$11.23B$5.44B14.7462,900Positive News
ALLE
Allegion
4.5907 of 5 stars
$128.18
+1.2%
$138.33
+7.9%
-5.2%$11.07B$3.77B18.8111,000Positive News
FTAI
FTAI Aviation
4.0094 of 5 stars
$107.00
+2.6%
$173.67
+62.3%
+64.1%$10.98B$1.73B-1,070.8940Gap Up
CART
Maplebear
3.9699 of 5 stars
$40.24
+4.3%
$50.52
+25.5%
+3.7%$10.63B$3.38B26.973,380Positive News
ULS
UL Solutions
1.6438 of 5 stars
$52.55
+0.6%
$51.45
-2.1%
N/A$10.51B$2.87B32.4215,233Positive News
MEDP
Medpace
4.1634 of 5 stars
$326.77
+0.6%
$381.44
+16.7%
-20.7%$9.96B$2.11B25.875,900Analyst Forecast
Positive News
STN
Stantec
2.2786 of 5 stars
$82.94
+0.6%
N/A-4.5%$9.47B$7.50B37.7228,000Positive News
BILI
Bilibili
1.726 of 5 stars
$22.47
+4.8%
$21.11
-6.0%
+81.8%$9.31B$26.83B-49.9312,300
WPP
WPP
2.3794 of 5 stars
$40.39
+1.3%
N/A-13.4%$8.71B$14.74B6.76114,732
HQY
HealthEquity
3.2016 of 5 stars
$99.73
+2.4%
$112.92
+13.2%
+6.6%$8.64B$1.15B91.523,150Analyst Forecast
Remove Ads

Related Companies and Tools


This page (NYSE:QBTS) was last updated on 3/24/2025 by MarketBeat.com Staff
From Our Partners